Heskin, J.
Pallett, S. J. C.
Al-Hindawi, A.
Davies, G. W.
Rayment, M.
Mughal, N.
Randell, P.
Jones, R.
Moore, L. S. P.
Funding for this research was provided by:
CW+
Westminster Medical School Research Trust
Article History
Received: 30 September 2021
Accepted: 11 May 2022
First Online: 25 May 2022
Competing interests
: JH received research funding from CW+ Charity and the Westminster Medical School Research Trust and received honoraria from Gilead (2020). SJCP has received a research Grant from the Scientific Exploration Society/Viscount Gough, outside the submitted work. NM has received speaker fees from Beyer (2016) and Pfizer (2019) and received educational support from Eumedica (2016) and Baxter (2017). LSPM has consulted for or received speaker fees from bioMerieux (2013–2022), Pfizer (2018–2022), Eumedica (2016–2022), DNAelectronics (2015–2018), Dairy Crest (2017–2018), Umovis Lab (2020–2021), Shionogi (2021–2022), Kent Pharma (2021), Sumitovant (2021–2022), and Pulmocide (2021), and received research grants from the National Institute for Health Research (2013–2019), CW+ Charity (2018–2022) and LifeArc (2020–2022). RJ has received honoraria, speaker fees, travel support and/or research grant funding from Gilead, ViiV Healthcare, BMS, Abbvie, Janssen and Merck. All other authors declare no competing interests.